Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/test-epi-composition/ and changes regularly. See the Directory of published versions
Full name:
Authorised dose form:
Legal status of supply:
Domain:
Resource status:
Product classification:
Document Details
Generated Narrative: Bundle TEST PURPOSES ONLY - novonorm
Language: en
Profile: Bundle - ePI
Final Document at 2022-02-16 13:28:17+0000 by Organization ACME industry for Bundle: identifier = http://ema.europa.eu/identifier#None; type = document; timestamp = 2023-06-27 10:09:22+0000
Document Subject
Generated Narrative: MedicinalProductDefinition mp3d8be59753418e73dbd90a9360e898ae
identifier: http://ema.europa.eu/identifier
/EU/1/98/076/004-006, EU/1/98/076/023
type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: NovoNorm 0.5 mg tablets
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en
Document Content
Generated Narrative: Composition composition-en-3d8be59753418e73dbd90a9360e898ae
Language: en
Profile: Composition (ePI)
identifier: http://ema.europa.eu/identifier
/EU/1/98/076/004-006, EU/1/98/076/023
status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - novonorm
Mode | Time |
Official | 2022-02-16 13:28:17+0000 |
What is in this leaflet
NovoNorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar (glucose).
Type 2 diabetes is a disease in which your pancreas does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces.
NovoNorm is used to control type 2 diabetes in adults as an add-on to diet and exercise: treatment is usually started if diet, exercise and weight reduction alone have not been able to control (or lower) your blood sugar. NovoNorm can also be given with metformin, another medicine for diabetes.
NovoNorm has been shown to lower the blood sugar, which helps to prevent complications from your diabetes.
Do not take NovoNorm
Warnings and precautions Talk to your doctor before taking NovoNorm:
Talk to your doctor if any of the above applies to you. NovoNorm may not be suitable for you. Your doctor will advise you.
Children and adolescents
Do not take this medicine if you are under 18 years of age.
If you get a hypo (low blood sugar)
You may get a hypo (short for hypoglycaemia) if your blood sugar gets too low. This may happen:
The warning signs of a hypo may come on suddenly and can include: cold sweat; cool pale skin; headache; rapid heart beat; feeling sick; feeling very hungry; temporary changes in vision; drowsiness; unusual tiredness and weakness; nervousness or tremor; feeling anxious; feeling confused; difficulty in concentrating. If your blood sugar is low or you feel a hypo coming on: eat glucose tablets or a high sugar snack or drink, then rest. When symptoms of hypoglycaemia have disappeared or when blood sugar levels are stabilised continue NovoNorm treatment. Tell people you have diabetes and that if you pass out (become unconscious) due to a hypo, they must turn you on your side and get medical help straight away. They must not give you any food or drink. It could choke you.
If your blood sugar gets too high
Your blood sugar may get too high (hyperglycaemia). This may happen:
The warning signs of too high blood sugar appear gradually. They include: increased urination; feeling thirsty; dry skin and dry mouth. Talk to your doctor. The amount of NovoNorm, food or exercise may need to be adjusted.
Other medicines and NovoNorm
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. You can take NovoNorm with metformin, another medicine for diabetes, if your doctor prescribes it. If you take gemfibrozil (used to lower increased fat levels in the blood) you should not take NovoNorm.
Your body s response to NovoNorm may change if you take other medicines, especially these:
NovoNorm with alcohol
Alcohol can change the ability of NovoNorm to reduce the blood sugar. Watch for signs of a hypo.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
You should not take NovoNorm if you are pregnant or you are planning to become pregnant.
You should not take NovoNorm if you are breast-feeding.
Driving and using machines
Your ability to drive or use a machine may be affected if your blood sugar is low or high. Bear in mind that you could endanger yourself or others. Please ask your doctor whether you can drive a car if you:
Always take this medicine exactly as your doctor has told you. Check with your doctor if you are not sure. Your doctor will work out your dose.
Do not take more NovoNorm than your doctor has recommended.
If you take more NovoNorm than you should
If you take too many tablets, your blood sugar may become too low, leading to a hypo. Please see If you get a hypo on what a hypo is and how to treat it.
If you forget to take NovoNorm
If you miss a dose, take the next dose as usual - do not double the dose.
If you stop taking NovoNorm
Be aware that the desired effect is not achieved if you stop taking NovoNorm. Your diabetes may get worse. If any change of your treatment is necessary contact your doctor first.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Hypoglycaemia The most frequent side effect is hypoglycaemia which may affect up to 1 in 10 patients (see If you get a hypo in section 2). Hypoglycaemic reactions are generally mild/moderate but may occasionally develop into hypoglycaemic unconsciousness or coma. If this happens, medical assistance is needed immediately.
Allergy Allergy is very rare (may affect up to 1 in 10,000 patients). Symptoms such as swelling, difficulty in breathing, rapid heartbeat, feeling dizzy and sweating could be signs of anaphylactic reaction. Contact a doctor immediately.
Other side effects Common (may affect up to 1 in 10 patients)
Rare (may affect up to 1 in 1,000 patients)
Very rare (may affect up to 1 in 10,000 patients)
Frequency not known
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and the blister foil after EXP. The expiry date refers to the last date of that month.
Store in the original package in order to protect from moisture.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Entry 1 - fullUrl = Composition/composition-en-3d8be59753418e73dbd90a9360e898ae
Resource Composition:
Generated Narrative: Composition composition-en-3d8be59753418e73dbd90a9360e898ae
Language: en
Profile: Composition (ePI)
identifier:
http://ema.europa.eu/identifier
/EU/1/98/076/004-006, EU/1/98/076/023status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - novonorm
Attesters
Mode Time Official 2022-02-16 13:28:17+0000
Entry 2 - fullUrl = MedicinalProductDefinition/mp3d8be59753418e73dbd90a9360e898ae
Resource MedicinalProductDefinition:
Generated Narrative: MedicinalProductDefinition mp3d8be59753418e73dbd90a9360e898ae
identifier:
http://ema.europa.eu/identifier
/EU/1/98/076/004-006, EU/1/98/076/023type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: NovoNorm 0.5 mg tablets
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en